Author： Elinor C.G. Chumney
Publisher： Adis International
ISSN： 1170-7690
Source： PharmacoEconomics, Vol.22, Iss.18, 2004-01, pp. : 1209-1216
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
Access to resources
Recommend
Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 2, Iss. 6, 2004-11 ,pp. :
Cambridge Scholars Publishing in association with GSE Research
ICD cost effectiveness over-rated?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 495, 2006-01 ,pp. :
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
By O'Hagan A.
PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. :